Skandinaviska Enskilda Banken Ab (Publ) Moderna, Inc. Transaction History

Skandinaviska Enskilda Banken Ab (Publ)

$21.5 Billion
Q3 2024

A detailed history of Skandinaviska Enskilda Banken Ab (Publ) transactions in Moderna, Inc. stock. As of the latest transaction made, Skandinaviska Enskilda Banken Ab (Publ) holds 79,803 shares of MRNA stock, worth $3.34 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

79,803

Previous 245,687 67.52%

Holding current value

$3.34 Million

Previous $29.2 Million 81.72%

% of portfolio

0.02%

Previous 0.14%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$63.64 - $125.14 $10.6 Million - $20.8 Million	-165,884 Reduced 67.52%	79,803 $5.33 Million
Q2 2024 Aug 13, 2024	BUY	$101.21 - $166.61 $71,454 - $117,626	706 Added 0.29%	245,687 $29.2 Million
Q1 2024 May 13, 2024	BUY	$85.37 - $115.44 $62,832 - $84,963	736 Added 0.3%	244,981 $26.1 Million
Q4 2023 Feb 14, 2024	SELL	$69.51 - $104.43 $525,982 - $790,221	-7,567 Reduced 3.01%	244,245 $24.3 Million
Q3 2023 Nov 09, 2023	SELL	$96.41 - $126.61 $5.05 Million - $6.63 Million	-52,345 Reduced 17.21%	251,812 $26 Million
Q2 2023 Aug 07, 2023	SELL	$118.5 - $160.53 $437,620 - $592,837	-3,693 Reduced 1.2%	304,157 $37 Million
Q1 2023 May 11, 2023	BUY	$135.66 - $197.02 $8.05 Million - $11.7 Million	59,310 Added 23.86%	307,850 $47.3 Million
Q4 2022 Feb 08, 2023	SELL	$118.38 - $210.04 $5.6 Million - $9.93 Million	-47,284 Reduced 15.98%	248,540 $44.6 Million
Q3 2022 Nov 14, 2022	BUY	$118.07 - $194.18 $2.97 Million - $4.88 Million	25,128 Added 9.28%	295,824 $35 Million
Q2 2022 Aug 10, 2022	BUY	$117.13 - $176.59 $10.4 Million - $15.7 Million	88,737 Added 48.77%	270,696 $38.7 Million
Q1 2022 May 11, 2022	SELL	$126.46 - $235.05 $3.77 Million - $7 Million	-29,788 Reduced 14.07%	181,959 $31.3 Million
Q4 2021 Feb 10, 2022	SELL	$225.82 - $368.51 $7.19 Million - $11.7 Million	-31,856 Reduced 13.08%	211,747 $53.3 Million
Q3 2021 Nov 10, 2021	BUY	$221.9 - $484.47 $23.1 Million - $50.3 Million	103,910 Added 74.38%	243,603 $93.8 Million
Q2 2021 Aug 10, 2021	BUY	$129.91 - $234.98 $3.52 Million - $6.37 Million	27,122 Added 24.09%	139,693 $32.8 Million
Q1 2021 May 14, 2021	SELL	$109.18 - $185.98 $2.36 Million - $4.02 Million	-21,602 Reduced 16.1%	112,571 $14.7 Million
Q4 2020 Feb 11, 2021	BUY	$65.74 - $169.86 $61,795 - $159,668	940 Added 0.71%	134,173 $14 Million
Q3 2020 Nov 12, 2020	BUY	$54.34 - $94.85 $787,712 - $1.37 Million	14,496 Added 12.21%	133,233 $9.43 Million
Q2 2020 Aug 13, 2020	BUY	$29.67 - $80.0 $3.51 Million - $9.47 Million	118,387 Added 33824.86%	118,737 $7.63 Million
Q1 2020 Jun 05, 2020	BUY	$17.78 - $31.58 $6,223 - $11,053	350 New	350 $10,000

Others Institutions Holding MRNA

# of Institutions

953

Shares Held

241M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $16.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Skandinaviska Enskilda Banken Ab (Publ), based on Form 13F filings with the SEC.

News

Stay updated on Skandinaviska Enskilda Banken Ab (Publ) with notifications on news.

Account

Skandinaviska Enskilda Banken Ab (Publ) Moderna, Inc. Transaction History